Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06068985
Title Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With HER2+ Early Breast Cancer Undergoing HER2 Double-Blockade (CHERRY-PICK)
Acronym CHERRY-PICK
Recruitment Not yet recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Latin American Cooperative Oncology Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries BRA


No variant requirements are available.